Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer
Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used as raw materials.


Pharmaceutical Technology
Volume 33, Issue 10, pp. 72-82


Figure 4: Confusion matrix for amino acid subset.
Amino acids. Of the 198 test materials, 12 were amino acids. Figure 4 shows p-value ranges for the pairings of amino acids. The green indicates p-values ≥0.1, a more stringent qualification than the test device's normal threshold of 0.05 for a pass result. For all amino acids, the test device correctly verified each material. The test device also correctly rejected nonmatching materials, with p-values ≤1 x 10–8 .


Figure 5: Confusion matrix for organic solvent subset.
Solvents. Test materials also included 15 organic solvents. Figure 5 shows p-value ranges for the test pairings of these solvents. The green area indicates p-values ≥0.1, again, a more stringent qualification than the test device's normal "pass" threshold of 0.05. For this category, the test device correctly verified each material. It also correctly rejected nonmatching materials, with p-values ≤1 x 10–8 , as indicated by red squares in Figure 5.


Figure 6: Confusion matrix for long-chain hydrocarbon subset.
Long-chain hydrocarbons. The p-values for 13 long-chain hydrocarbons are shown in Figure 6. Unlike the other categories of test substances discussed previously, some of these pairings resulted in higher p-values when a method was tested against a similar material in this class of compounds. For larger molecules such as these, the Raman signal corresponding to the long hydrocarbon chain portion of the molecule can dominate the signal making spectral features arising from other functional groups difficult to detect. This is in contrast to small molecules where single atomic or functional group substitutions are easily detected (e.g. acetone/methyl ethyl ketone and calcium sulfate/magnesium sulfate).


Categories of materials.
In almost all cases, the long-chain hydrocarbon pairings produced exclusive (completely selective), pass verdicts with p-values >0.1, indicated by green in Figure 6. The one exception was the magnesium stearate–sorbitan monopalmitate pairing. In this case, the Raman signal from the long-chain hydrocarbon (differing between the two materials by only one carbon) overwhelms differences present in the rest of the molecule. About half of the negative pairings produced very low p-values ≤1 x 10–8 , indicated by red in Figure 6. Nineteen pairings of long-chain hydrocarbons resulted in p-values in the range of 0.01 to 0.1 (yellow in Figure 6). Off-diagonal p-values in this range represent cases in which clear gaps in selectivity between methods exist (p-value >0.05) or where the pairings are not so far removed, lying in the 0.01–0.05 range, that there is risk for inadequate selectivity. It is important to identify materials like these during method validation to identify potential false positives and assess their degree of risk. Another group, the 54 pairings indicated by orange in Figure 6, produced p-values in the range 1 x 10–8 to 0.01 which are of significantly less concern during method validation and robustness testing.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here